Palatin Technologies Inc (PTN): R&D Expense
$12.37M
Year ended 2026-06-30
$13.23M
Trailing 12 months to 2026-09-30
-18.2%
3-year compound annual growth
-0.9%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $12.37M | -17.0% | 2026-09-28, From 2025-07-01 |
| 2025-06-30 | $14.90M | -33.5% | 2026-09-28, From 2024-07-01 |
| 2024-06-30 | $22.40M | -1.0% | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | $22.63M | +6.1% | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | $21.33M | +65.0% | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | $12.93M | -7.4% | 2022-09-22, From 2020-07-01 |
| 2020-06-30 | $13.96M | -6.0% | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | $14.86M | -54.4% | 2020-09-25, From 2018-07-01 |
| 2018-06-30 | $32.57M | n/c | 2019-09-12, From 2017-07-01 |
| 2017-06-30 | $32.57M | n/c | 2020-09-25, From 2016-07-01 |
| 2016-06-30 | $43.07M | +75.4% | 2018-09-13, From 2015-07-01 |
| 2015-06-30 | $24.56M | +126.8% | 2017-09-25, From 2014-07-01 |
| 2014-06-30 | $10.83M | +2.8% | 2016-09-19, From 2013-07-01 |
| 2013-06-30 | $10.53M | -23.8% | 2015-09-18, From 2012-07-01 |
| 2012-06-30 | $13.81M | +33.1% | 2014-09-12, From 2011-07-01 |
| 2011-06-30 | $10.38M | -15.6% | 2013-09-27, From 2010-07-01 |
| 2010-06-30 | $12.29M | n/a | 2012-09-10, From 2009-07-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Palatin Technologies Inc (PTN) | 2026-06-30 | $12.37M | -17.0% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $44.49M | +11.3% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $74.04M | +15.3% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $122.0K | +3.4% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $73.70M | +25.4% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $313.0K | -52.4% |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | $25.24M | -53.3% |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | $30.81M | +14.8% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $94.30M | -20.1% |
Compare PTN, TNXP, EVMN, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗